FREE MAMMOGRAM FOR WOMEN 40 AND ABOVENOV 19, 2019 @ 9.02 AM
Datuk Seri Dr Haji Dzulkefly Ahmad, the Minister of Health launcing Etiqa’s Free Mammogram Programme (Phase 3) accompanied by Dr Saunthari Somasundaram, President of National Cancer Society Malaysia and the rest.
Underpriviledged women aged 40 and above can now take full advantage of Etiqa’s Free Mammogram Programme – Phase 3 which was launched in partnership with the National Cancer Society of Malaysia (NCSM).
This is the third phase of Etiqa and NCSM’s commitment to address women’s health, this time by providing 6000 free breast cancer screening for underprivileged women, aged 40 and above. The one-year, nationwide programme is worth RM2 million and falls under Etiqa Cares, Etiqa’s flagship corporate responsibility commitment towards healthy living. This follows the successful completion of Phase 1 and Phase 2 of Etiqa’s Free Mammogram Programme, where a total of RM4.52 million was contributed towards free mammograms that has benefitted 11,000 underprivileged women across Peninsular Malaysia. The partnership, which was first launched in July 2017 saw Etiqa and NCSM embarking on a journey to raise awareness amongst underprivileged women on the importance of early detection in improving breast cancer survival rates. Eligible women from communities around the country were transported to the NCSM Centre or appointed hospitals for free mammograms. Breast cancer is the most common cancer among Malaysian women. More women are dying of breast cancer than other countries despite having a lower incidence risk of 1 in 30 in their lifetime. This is primarily due to late diagnosis. According to the National Cancer Registry Report 2007 to 2011, 43% of women only discovered they had breast cancer at later stages (stage 3 and 4). Eligible women and interested community leaders are encouraged to call Dina from NCSM at 03-2698 7300 for more enquiries on the free mammogram programme. 
|
Roche launch Perjeta - Herceptin combination, a post surgery treatment for early breast cancer (eBC)
Keytruda with chemotherapy to be the first line of treatment for patients with advanced lung cancer
|
Copyright@ 2018 Healthcare Today. All rights reserved. The material in this site is intended to be of general information use and is not intended to constitute medical
advice, probable diagnosis or recommended treatments.
advice, probable diagnosis or recommended treatments.